Back
Bristol-Myers Squibb Vs. Viking Therapeutics Industry Stock Comparison
Buy
56
BMY
Bristol-Myers Squibb
Last Price:
48.71
Seasonality Move:
4.14%
Sell
47
VKTX
Viking Therapeutics
Last Price:
54.13
Seasonality Move:
8.99%
Buy
56
Bristol-Myers Squibb (BMY)
is a Buy
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $48.70. The Score for BMY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- BMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $54.16. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $48.70
The current trend is moderately bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $54.16
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
BMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.93 | Buy |
Relative Strength Index (14 RSI): | 53.4 | Buy |
Chaikin Money Flow: | -8468353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.44 - 49.62) | Buy |
Bollinger Bands (100): | (41.36 - 47.98) | Buy |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 40.93 | Sell |
Chaikin Money Flow: | 868119 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.37 - 63.73) | Sell |
Bollinger Bands (100): | (52.14 - 69.1) | Sell |
BMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.48 | Sell |
20-day SMA: | 48.81 | Sell |
50-day SMA: | 45.81 | Buy |
200-day SMA: | 47.73 | Buy |
8-day EMA: | 49.36 | Sell |
20-day EMA: | 48.67 | Buy |
50-day EMA: | 46.93 | Buy |
200-day EMA: | 48.77 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.42 | Sell |
20-day SMA: | 60.55 | Sell |
50-day SMA: | 56.97 | Sell |
200-day SMA: | 50.23 | Buy |
8-day EMA: | 58.53 | Sell |
20-day EMA: | 59.39 | Sell |
50-day EMA: | 58.62 | Sell |
200-day EMA: | 50.21 | Buy |
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.24 per share, a decrease this year of $6.64 per share, and an increase next year of $6.23 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.59 per share.
Bristol-Myers Squibb Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |